Skip to main content
Kits Eyecare Ltd. logo

Kits Eyecare Ltd. — Investor Relations & Filings

Ticker · KITS ISIN · CA49804N1042 LEI · 254900QPUEPAYH33G850 TSX Wholesale and retail trade
Open in API
Filings indexed 177 across all filing types
Latest filing 2023-03-09 Regulatory Filings
Country CA Canada
Listing TSX KITS

About Kits Eyecare Ltd.

https://www.kits.ca/

Kits Eyecare Ltd. operates a direct-to-consumer digital eyecare platform providing high-quality, affordable vision products, including prescription eyeglasses, sunglasses, and contact lenses, to customers across the United States and Canada. The company utilizes innovative technology to streamline the purchasing process and disrupt the traditional eyewear industry. Kits maintains vertical integration through its state-of-the-art optical lab located in Vancouver, where lenses are crafted and glasses are tailored to customer prescriptions. This infrastructure supports its position as one of the largest digital eyecare providers in Canada.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2023-03-09 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification form titled 'FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE' signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The content focuses on the officer's attestation regarding the accuracy and controls over the interim filings, referencing National Instrument 52-109. There are no actual financial statements or substantive financial data presented in the document itself; it is purely a certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is short (3244 characters), consistent with a certification letter rather than a full report.
2022-11-09 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification form (FORM 52-109F2) signed by the CEO certifying the accuracy and fairness of the interim financial report and interim MD&A for the period ended September 30, 2022. It does not contain the actual interim financial data or analysis but is an attestation regarding the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself. The document length is short (3141 characters) and is a full certificate, not the report. Therefore, the correct classification is Regulatory Filings (RNS).
2022-11-09 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for the three and nine months ended September 30, 2022 and 2021. It contains detailed financial statements including statements of income, comprehensive income, financial position, changes in equity, and cash flows, along with notes to the financial statements. The document explicitly states it is prepared in accordance with IAS 34, Interim Financial Reporting, indicating it is an interim report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-11-09 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2022,' which clearly indicates it is a Management Discussion and Analysis (MD&A) report. It contains detailed financial data, operational results, forward-looking statements, and non-IFRS measures for the interim period ending September 30, 2022. The presence of unaudited condensed interim consolidated financial statements and substantive financial data confirms this is a comprehensive interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-11-09 English
News release - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of Kits Eyecare Ltd.'s financial results for the third quarter of 2022. It includes comprehensive financial data such as revenue, gross profit, net income, EBITDA, and adjusted EBITDA for the three and nine months ended September 30, 2022, and 2021. It also contains management commentary on the results, forward-looking statements, and information about a conference call to discuss the results. The presence of unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis (MD&A) references indicates this is a quarterly financial report. The document is over 11,000 characters, so it is not a brief announcement or a report publication announcement. It contains substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR).
2022-11-09 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.